STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo battle for lung cancer survival
Disease control OngoingThis study is for people with advanced or recurrent non-small cell lung cancer that has a specific genetic change (EGFR mutation). It compares two treatment approaches: taking a pill called afatinib alone, or taking afatinib plus receiving an IV drug called cetuximab. The main go…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2, PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New hope for Tough-to-Treat lung cancer patients
Disease control OngoingThis early-stage study is testing whether combining two existing cancer drugs—ceritinib and docetaxel—can help control advanced lung cancer that has stopped responding to standard chemotherapy. The trial aims to find the safest dose of this combination and see if it can shrink tu…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug cocktail tested in fight against tough cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of a new drug called sEphB4-HSA when given alongside standard chemotherapy. It involves about 61 people with specific advanced or spreading cancers, including pancreatic, lung, and head/neck cancers, that have stopped res…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
CRISPR-Engineered immune cells target advanced lung cancer
Disease control TerminatedThis trial aimed to test a new cell therapy for metastatic non-small cell lung cancer. It planned to use a patient's own tumor-fighting immune cells, genetically edited with CRISPR technology to remove a molecular 'brake' called CISH. The goal was to see if these supercharged cel…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Radiation boost after chemo tested to keep lung cancer at bay
Disease control OngoingThis trial is for people with advanced non-small cell lung cancer that has spread to only a few other body sites. It tests whether adding targeted radiation or surgery to the areas where cancer remains, on top of ongoing maintenance chemotherapy, helps control the cancer better a…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Blood test could predict which cancer treatments will work
Knowledge-focused OngoingThis study aims to develop a blood test algorithm that can predict how well cancer treatments will work for patients with advanced lung cancer or melanoma. Researchers will analyze blood samples from 10,000 patients before and during their standard cancer treatments to identify p…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC